Your session is about to expire
← Back to Search
Autologous Platelet Rich Plasma for Erectile Dysfunction
Study Summary
This trial is to see if PRP, a treatment made from a person's own blood, is safe and effective in treating ED.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2023 Phase 2 trial • 61 Patients • NCT04396795Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a mental health condition that affects your ability to have or maintain an erection.You have been experiencing erectile dysfunction for more than 1 year but less than 5 years.You have had difficulty getting or maintaining an erection for more than a year but less than five years.You have been experiencing erectile dysfunction for more than a year but less than 5 years.You are currently taking medications to thin your blood.You are a patient who is PDE5i responsive.You have a history of diabetes.You have a history of heart disease involving the blood vessels.You have had previous cancer in your pelvic area.You have a neurological condition that affects your ability to have an erection, such as a spinal cord injury or nerve damage in the pelvic area.
- Group 1: Platelet Rich Plasma Treatment
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies for individuals seeking to participate in this clinical research?
"It appears that, based on the information available via clinicaltrials.gov, this trial is actively recruiting participants as of November 14th 2022; it was originally posted four months prior to this date."
Has the FDA sanctioned Autologous Platelet Rich Plasma for therapeutic use?
"The safety of Autologous Platelet Rich Plasma receives a score of 1 since this trial is in the initial testing phase, meaning there are few studies proving its efficacy and reliability."
Is age a limiting factor for eligibility in this investigation?
"The entry criteria for this medical trial requires a participant to be no older than 65 years and at least 45 years of age."
Am I eligible to partake in this experiment?
"The trial is recruiting 15 men aged between 45 and 65 who suffer from erectile dysfunction. Qualified candidates must present a signed informed consent form, have experienced their disorder for one to five years, be in a stable relationship of three months or more, fulfil the criteria set out by IIEF-EF, EHS, SEP 2+3 and GAQ Domain scores 17-20 Mild to moderate vascular erectile dysfunction with PSV > 25 cm/sec as well as demonstrate PDE5i responsiveness - i.e., they can attain an erection under maximal dosage of PDE5i."
How many individuals is the research group recruiting for this experiment?
"Affirmative. Clinicaltrials.gov reflects that this clinical trial is presently enrolling applicants; it was initially advertised on March 4th 2022 and updated lastly on November 14th 2022. The research initiative seeks to recruit 15 participants from a single site."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Mayo Clinic in Florida: < 24 hours
Average response time
- < 1 Day
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger